Table 1.
Characteristics of pilot trial participants by treatment arm.
| Characteristicsa | All participants (n=120) | Control (n=59) | Intervention (n=61) | |
| Age (years), mean (SD) | 72.1 (9.10) | 72.6 (7.28) | 71.7 (10.6) | |
| Female gender, n (%) | 62 (51.7) | 30 (50.8) | 32 (52.5) | |
| White race, n (%) | 111 (92.5) | 54 (91.5) | 57 (93.4) | |
| BMI (m/kg2), mean (SD) | 30.9 (6.79) | 31.0 (5.92) | 30.8 (7.61) | |
| Smoking history, n (%) | ||||
|
|
Never | 63 (52.5) | 30 (50.8) | 33 (54.1) |
|
|
Former | 53 (44.1) | 25 (42.4) | 28 (45.9) |
|
|
Current | 4 (3.3) | 4 (6.8) | 0 (0.0) |
| Heart failure, n (%) | 24 (20.0) | 14 (23.7) | 10 (16.4) | |
| Preserved, n (%) | 15 (12.5) | 9 (15.3) | 6 (9.8) | |
| Reduced, n (%) | 9 (7.5) | 5 (8.5) | 4 (6.6) | |
| Hypertension, n (%) | 105 (87.5) | 50 (84.7) | 55 (90.2) | |
| Diabetes, n (%) | 29 (24.2) | 17 (28.8) | 12 (19.7) | |
| Stroke/TIAb, n (%) | 1 (0.8) | 1 (1.7) | 0 (0.0) | |
| Vascular disease, n (%) | 30 (25.0) | 15 (25.4) | 15 (24.6) | |
| Education, n (%) | ||||
|
|
High school/vocational | 34 (28.3) | 21 (35.6) | 13 (21.3) |
|
|
Some college | 13 (10.8) | 6 (10.2) | 7 (11.5) |
|
|
Bachelor’s degree | 33 (27.5) | 17 (28.8) | 16 (26.2) |
|
|
Graduate | 40 (33.3) | 15 (25.4) | 25 (41.0) |
| Income (US $), n (%) | ||||
|
|
<19,999 | 10 (8.3) | 6 (10.2) | 4 (6.6) |
|
|
20,000-49,999 | 32 (26.7) | 17 (28.8) | 15 (24.6) |
|
|
50,000-99,999 | 30 (25.0) | 13 (22.0) | 17 (27.9) |
|
|
>100,000 | 25 (20.8) | 11 (18.6) | 14 (23.0) |
| S-TOFHLAc, mean (SD) | 30.1 (4.5) | 30.3 (4.0) | 30.0 (4.9) | |
| S-TOFHLA ≤23, n (%) | 10 (8.3) | 4 (6.8) | 6 (9.8) | |
| PHQ-9d score, (units) | 3 (1-4) | 3 (1-6) | 3 (1-4) | |
aContinuous variables are presented as mean (SD), and categorical variables are presented as number (percentage).
bTIA: transient ischemic attack.
cS-TOFHLA: Short-Test Of Functional Health Literacy in Adults.
dPHQ-9: Patient Health Questionnaire-9.